Are We There Yet? Agent Agnostic Metagenome Sequencing for Biothreat Detection Biodetection July 31, 2024 …
BARDA Looks to Advance Metagenomic Next-Generation Sequencing (mNGS) Biodetection February 12, 2024 …
NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and Flu Biodetection February 1, 2024 …
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
Inflammatix Completes Development for Acute Infection and Sepsis Test System Biodetection November 15, 2023 …
Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance Biodetection September 19, 2023 …
The Need for Speed in Biodefense: How JPEO-CBRND is Positioning for Rapid Response CBRNE August 11, 2023 …
BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel Biodetection August 1, 2023 …
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus Health Security May 3, 2022 …
Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization Biodetection March 19, 2022 …
US Government Invests in At-Home Single Swab Combined Flu, COVID Test Biodetection February 3, 2022 …
